Enzymatica AB (publ)

kr 2.45As of Sun 8 Nov 2026, 12:00 UTC
STO:ENZYHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (3.84%)
Div yield —
ROE (36.11%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.53)
PE TTM —
TSR TTM 26.94%
Mkt cap kr 594.7M
ROIC (20.60%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 2.60
6.15%
(30.22%)
Hold 0|11|7|6|5
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.05
0.06
0.06
0.07
23.87%
21.34%
23.68%
42.86%
Revenuekr M
45.93
48.12
48.72
48.87
14.21%
14.11%
9.51%
7.59%
Peers (US$60.12M)
Cap (US$)
PE
59.32M
22.19x
Capital
TTM
5Y
10Y
Leveragex
0.539
0.237
0.185
EBIT/Intx
1.459
0.742
0.704
Own earn%
703.07
21.42
25.50
Sh yield%
24.05
31.73
29.88
Owners
Insiders/Inst%
9.28
87.36
Short interest%
4.49
SBC / revenue%
4.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
17–24
$1 testx
0.0
Incr. ROIC%
23